LOS ANGELES, July 26, 2021 (GLOBE NEWSWIRE) — Eyenuk, Inc., a worldwide synthetic intelligence (AI) medical know-how and providers firm and the chief in real-world functions for AI Eye Screening, introduced that its EyeArt® AI system for diabetic eye testing has been chosen for deployment in 4 hospitals in Binh Dinh Province, Vietnam. The mission is funded by The Fred Hollows Basis.
“We’re excited to implement the EyeArt AI system to broaden our capabilities in detection and therapy of diabetic retinopathy. It would assist us attain our objective to guard the imaginative and prescient of roughly six million folks with diabetes dwelling in Vietnam,” stated Pham Quoc Anh, Vietnam Nation Supervisor for The Fred Hollows Basis. “This vital mission will assist us proceed the work first began by Professor Fred Hollows 29 years in the past, fulfilling his imaginative and prescient to deliver equitable eye well being for all.”
The Fred Hollows Basis is a non-profit help organisation based mostly in Sydney, Australia, which was based in 1992 by eye surgeon Fred Hollows. The Basis focuses on treating and stopping blindness and different imaginative and prescient issues. It operates in Australia, South East Asia, East Asia, the Center East, and Africa, and has restored sight to over two and a half million folks.
In 2020, the Fred Hollows Basis contributed to greater than 860,000 years of high quality sight saved, bettering and defending the sight of over 100,000 folks via cataract surgical procedures, addressing refractive error, trachoma surgical procedures and diabetic retinopathy remedies. In Vietnam, The Basis’s work on diabetic retinopathy is supported by the Australian Authorities via the Australian NGO Cooperation Program.
In regards to the EyeArt AI System
The EyeArt AI System offers totally automated diabetic retinopathy (DR) screening, together with retinal imaging, DR detection based mostly on worldwide scientific requirements and fast reporting, in a single workplace go to throughout a diabetic affected person’s common examination. As soon as the affected person’s fundus photos have been captured and submitted to the EyeArt AI System, the DR detection outcomes can be found in a PDF report in lower than 30 seconds.
The EyeArt AI System was developed with funding from the U.S. Nationwide Institutes of Well being (NIH) and is validated by the U.Ok. Nationwide Well being Service (NHS). Along with U.S. Meals and Drug Administration (FDA) 510(ok) clearance, the EyeArt AI System has CE marking as a category 2a medical machine within the European Union and a Well being Canada license. It’s designed to be Basic Information Safety Regulation (GDPR) and Well being Insurance coverage Portability and Accountability Act of 1996 (HIPAA) compliant.
The EyeArt System is reimbursed by authorities and personal payors within the U.S. below the newly created Present Procedural Terminology (CPT) code 92229. Medicare began its nationwide protection for CPT 92229 on January 1, 2021.
About Eyenuk, Inc.
Eyenuk, Inc. is a worldwide synthetic intelligence (AI) medical know-how and providers firm and the chief in real-world AI Eye Screening for autonomous illness detection and AI Predictive Biomarkers™ for danger evaluation and illness surveillance. Eyenuk is on a mission to display each eye on the earth to make sure well timed analysis of life- and vision-threatening illnesses, together with diabetic retinopathy, glaucoma, age-related macular degeneration, stroke danger, cardiovascular danger, and Alzheimer’s illness. Discover Eyenuk on-line on its website, Twitter, Facebook, and LinkedIn.
Eyenuk, Inc. Contact
Frank Cheng, President & CCO
+1 818 835 3585